- Home
- TAC vs INSP Comparison
TAC vs INSP Comparison
Compare TAC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAC
- INSP
- Stock Information
- Founded
- TAC 1909
- INSP 2007
- Country
- TAC Canada
- INSP United States
- Employees
- TAC N/A
- INSP N/A
- Industry
- TAC Electric Utilities: Central
- INSP Medical/Dental Instruments
- Sector
- TAC Utilities
- INSP Health Care
- Exchange
- TAC Nasdaq
- INSP Nasdaq
- Market Cap
- TAC 4.3B
- INSP 3.8B
- IPO Year
- TAC N/A
- INSP 2018
- Fundamental
- Price
- TAC $14.95
- INSP $77.07
- Analyst Decision
- TAC Buy
- INSP Buy
- Analyst Count
- TAC 3
- INSP 15
- Target Price
- TAC $19.83
- INSP $154.00
- AVG Volume (30 Days)
- TAC 1.3M
- INSP 1.0M
- Earning Date
- TAC 11-04-2025
- INSP 11-03-2025
- Dividend Yield
- TAC 1.19%
- INSP N/A
- EPS Growth
- TAC N/A
- INSP 756.73
- EPS
- TAC N/A
- INSP 1.74
- Revenue
- TAC $1,838,165,207.00
- INSP $861,312,000.00
- Revenue This Year
- TAC N/A
- INSP $14.85
- Revenue Next Year
- TAC N/A
- INSP $14.64
- P/E Ratio
- TAC N/A
- INSP $44.09
- Revenue Growth
- TAC N/A
- INSP 22.05
- 52 Week Low
- TAC $7.82
- INSP $70.77
- 52 Week High
- TAC $15.01
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- TAC 80.40
- INSP 41.93
- Support Level
- TAC $13.52
- INSP $70.77
- Resistance Level
- TAC $14.90
- INSP $77.83
- Average True Range (ATR)
- TAC 0.38
- INSP 2.82
- MACD
- TAC 0.11
- INSP 0.71
- Stochastic Oscillator
- TAC 97.25
- INSP 50.02
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.